Hitachi Energy Japan Recognized as a 2026 Health & Productivity Management Outstanding Organization (Large Enterprise Category) JCN Newswire

Hitachi Energy Japan Recognized as a 2026 Health & Productivity Management Outstanding Organization (Large Enterprise Category)

TOKYO, Mar 16, 2026 - (JCN Newswire via SeaPRwire.com) - Hitachi Energy Japan Ltd. has been recognized as a 2026 Health & Productivity Management Outstanding Organization (Large Enterprise Category) under the recognition program, jointly administered by Japan’s Ministry of Economy, Trade and Industry (METI) and Nippon Kenko Kaigi (Japan Health Council).Since 2023, the company has been recognized in the Small and Medium‑Sized Enterprise Category for three consecutive years. In 2026, Hitachi Energy in Japan was recognized for the first time in the Large Enterprise Category, reflecting its workforce growth. Organizations certified in this category are expected to lead by example, extending health and productivity management beyond their own operations to group companies, business partners, local communities, customers, and employees’ familiesPeople‑Centric HSE as a Foundation for the Energy TransitionAt Hitachi Energy, we promote “Health and Productivity Management”—activities designed to maintain and enhance employee health—guided by the Hitachi Group Safety and Health Policy, whose core principle is that safety and health always come first, and our global HSE*1 policy, which focuses on improving health and well‑being in the workplace.*1 Health, Safety, and Environment.With people at the heart of everything we do, Hitachi Energy views health and productivity management as a management foundation that underpins corporate value and social trust. By fostering a safe and healthy work environment through shared responsibility and continuous improvement, the company reinforces its role in advancing the energy transition and shaping a sustainable energy future for all.About the Health & Productivity Management Outstanding Organization Recognition ProgramThe Health & Productivity Management Outstanding Organization Recognition Program is a program established by Japan’s Ministry of Economy, Trade and Industry (METI) in fiscal year 2016. The program highlights large enterprises and small and medium‑sized enterprises that are implementing particularly excellent health and productivity management, and aims to develop an environment in which such organizations can gain enhanced recognition from employees, job seekers, related companies, and financial institutions. Marking its 10th year, the 2026 program recognized 3,765 organizations in the Large Enterprise Category and 23,085 organizations in the Small and Medium‑Sized Enterprise Category.ReferenceNippon Kenko Kaigi (Japan Health Council) – Official Website (Japanese)ACTION! Health & Productivity Management – Portal SiteAbout Hitachi EnergyHitachi Energy is a global technology leader in electrification, powering a sustainable energy future with innovative power grid technologies with digital at the core. Over three billion people depend on our technologies to power their daily lives. With over a century in pioneering mission-critical technologies like high-voltage, transformers, automation, and power electronics, we are addressing the most urgent energy challenge of our time – balancing soaring electricity demand, while decarbonizing the power system. With an unparalleled installed base in over 140 countries, we co-create and build long-term partnerships across the utility, industry, transportation, data centers, and infrastructure sectors. Headquartered in Switzerland, we employ over 50,000 people in 60 countries and generate revenues of around $16 billion USD.https://www.hitachienergy.comhttps://www.linkedin.com/company/hitachienergyhttps://x.com/HitachiEnergyAbout Hitachi, Ltd.Through its Social Innovation Business (SIB) that brings together IT, OT (Operational Technology) and products, Hitachi contributes to a harmonized society where the environment, wellbeing, and economic growth are in balance. Hitachi operates globally in four sectors – Digital Systems & Services, Energy, Mobility, and Connective Industries – and the Strategic SIB Business Unit for new growth businesses. With Lumada at its core, Hitachi generates value from integrating data, technology and domain knowledge to solve customer and social challenges. Revenues for FY2024 (ended March 31, 2025) totaled 9,783.3 billion yen, with 618 consolidated subsidiaries and approximately 280,000 employees worldwide. Visit us at www.hitachi.com Copyright 2026 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com
More
Bonus Savings Account: What It Is and How It Helps You Earn More Interest ACN Newswire

Bonus Savings Account: What It Is and How It Helps You Earn More Interest

SINGAPORE, Mar 16, 2026 - (ACN Newswire via SeaPRwire.com) - In a world where living costs continue to rise, making your money work harder for you is a necessity. While a standard savings account offers a base interest rate, a bonus savings account allows you to earn higher interest by meeting specific conditions.By understanding the mechanics of these accounts, you can turn your idle cash into a productive asset. This article explores the features of these accounts and how they can help you reach your financial goals sooner.What is a Bonus Savings Account?A bonus savings account is a type of bank account that rewards you with higher interest rates when you meet specific conditions. Unlike a basic account that pays a flat, low rate regardless of your activity, these accounts are designed to encourage healthy financial habits.Generally, your total interest is split into two parts: base interest and bonus interest. The base interest is what you earn on every dollar, regardless of your activity. The bonus interest is an additional percentage added when you fulfil certain requirements, such as increasing your monthly balance or spending on a linked credit card.How a Bonus Savings Account Helps You Earn MoreThe primary appeal of a bonus savings account is the ability to earn interest rates that are often several times higher than standard savings accounts. Here is how they help you maximise your earnings:1. Rewarding Consistent Savers: Many accounts reward you for not spending your money. For example, some accounts offer bonus interest if your monthly average balance increases compared to the previous month. This encourages you to keep your funds in the account rather than withdrawing them for impulsive purchases, allowing compounding to work in your favour.2. Consolidating Your Financial Activities: Banks often use a bonus savings account to reward loyalty. You might earn extra interest by linking your salary credit or meeting a minimum spend on the bank's credit cards. By centring your financial activities around one account, you can unlock higher tiers of interest than with a basic savings plan.3. Tiered Interest Structures: Most bonus accounts use a tiered system. This means that as your balance grows, the interest rate on specific brackets of your funds increases. This structure is particularly beneficial for those with growing savings, as it allows larger balances to earn higher rates.Common Requirements to Unlock Bonus InterestTo make the most of a bonus savings account, you need to understand the typical requirements. Banks in Singapore usually look for the following:Balance Growth: Maintaining or increasing your balance month on month.Salary Credit: Having your monthly take-home pay credited directly into the account via your employer.Spend Requirements: Using a linked debit or credit card for a minimum amount (often SGD 500) each month.Investing or Insuring: Purchasing eligible insurance or investment products through the bank.Is a Bonus Savings Account Right for You?While the high interest rates are attractive, a bonus savings account is most effective when it aligns with your natural spending and saving habits.If you are someone who saves a portion of your income every month and rarely withdraws from your reserves, an account that rewards balance growth is an excellent fit. However, if you prefer an account that doesn't require you to track credit card spending or investment tiers, you may want to consider a simpler savings account.Strategies to Maximise Your InterestTo ensure you never miss out on your bonus interest, consider these simple steps:Automate Your Savings: Set up a standing instruction to move a fixed amount into your bonus savings account every month. This ensures your balance grows consistently without you having to remember to do it manually.Track Your Monthly Average Balance: Be mindful of the mid-month balance rather than just the balance on the last day of the month. Large withdrawals in the middle of the month may lower your average balance.Consolidate Spending: If your account requires a minimum card spend, try to put all your essential costs, such as groceries, transport, and utilities, on that specific card to hit the target easily.Final ThoughtsA bonus savings account can be a useful tool for improving returns on your cash savings. It transforms the act of saving from a passive habit into a rewarding strategy. By choosing an account that fits your lifestyle and staying disciplined with the requirements, you can help your hard-earned money grow at a higher rate.Disclaimer: This article is for general information only and does not have any regard to the specific investment objectives, financial situation and particular needs of any specific person. The views expressed in this article are solely those of the author. This article shall not be regarded as an offer, recommendation, solicitation or advice. You may wish to consult your own professional advisers about this article, in particular, a financial professional before making financial decisions. Any past events, trends and/or performance referred to in this article may not necessarily be indicative of future events, trends or performance. This article is based on certain assumptions and reflects prevailing conditions as at the time of publication, which are subject to change at any time without notice. The author and publisher of this article as well as any other parties associated with this article make no representation or warranty of any kind, whether express, implied or statutory, in respect of this article and accept no liability or responsibility for the completeness or accuracy of this article or any error, inaccuracy or omission relating to this article and/or any consequence, injury, loss or damage howsoever suffered by any person relating to this article, in particular, arising from any reliance by any person on this article. Publishers or platforms may be compensated for access to third party websites.Contact Information:Name : Sonakshi MurzeEmail : Sonakshi.murze@iquanti.comJob Title : ManagerSOURCE: iQuanti Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
CMS (867.HK/8A8.SG) : New Drug for Renal Anaemia Desidustat Tablets Approved in China SeaPRwire

CMS (867.HK/8A8.SG) : New Drug for Renal Anaemia Desidustat Tablets Approved in China

SHENZHEN, CHINA, Mar 13, 2026 – (ACN Newswire via SeaPRwire.com) – China Medical System Holdings Limited (“CMS”, or the “Group”) is pleased to announce that on 13 March 2026, new drug for renal anaemia Desidustat Tablets (the “Product”) has been approved for marketing in China by the National Medical Products Administration of the People’s Republic of China (NMPA). The Product is a novel, oral HypoxiaInducible Factor-Prolyl Hydroxylase Inhibitor (HIF-PHI) for treating anaemia in non-dialysis adult, Chronic Kidney Disease (CKD) patients. The approval of Desidustat Tablets will further strengthen the Group’s overall layout in the field of nephrology, and synergize with the marketed innovative drug Velphoro (Sucroferric Oxyhydroxide Chewable Tablets, indicated for CKD hyperphosphatemia). Through the efficient linkage of nephrology expert resources and channel networks, the Group is expected to rapidly promote the large-scale clinical application of Desidustat Tablets, providing differentiated treatment options for Chinese CKD patients with renal anaemia and making a positive contribution to the Group’s performance. More information about Desidustat Tablets and Renal Anaemia As a novel oral HIF-PHI, the Product’s mechanism of action promotes erythropoiesis through increasing endogenous erythropoietin, improving iron availability and reducing hepcidin. Its China Phase III clinical trial has demonstrated positive results. The primary endpoint of the haemoglobin (Hb) mean change from baseline to Week 7-9 has indicated that, Desidustat is more effective than placebo in increasing Hb level. Results from the extension study demonstrate that the Product can maintain Hb level within the target range over the long term with acceptable safety. In addition, the Product significantly reduces hepcidin levels and ameliorates iron metabolism disorders. There is still a large unmet need in the treatment of anaemia in CKD patients in China. It is estimated that there are more than 120 million CKD patients in China[1]. Anaemia is one of the frequent complications of CKD, which exhibits a progressively increasing incidence with disease progression. A survey in China showed that the prevalences of anaemia in patients at CKD stage 1 to 5 were 22.0%, 37.0%, 45.4%, 85.1%, and 98.2%, respectively[2]. The target-achieving rate (the Hb level reaching the target value (110~120g / L)) has increased to 51.5% for haemodialysis CKD patients with anaemia[3], but is still only 8.2% for anaemia patients in non-dialysis CKD[4]. The Product is administrated orally, thus expecting to improve the treatment compliance of patients and to meet the unmet treatment needs in the field of CKD anaemia. Desidustat Tablets have been approved for marketing in India. CMS INTERNATIONAL DEVELOPMENT AND MANAGEMENT LIMITED, a wholly-owned subsidiary of the Group, obtained an exclusive license for the Product from Zydus Lifesciences Limited (earlier known as Cadila Healthcare Limited) pursuant to a License Agreement with an effective date of 20 January 2020. The Group adheres to its core strategy of “innovation-driven”, having established a tiered and multi-dimensional innovation product portfolio with abundant reserves: 7 new drugs have been approved for marketing, 6 are currently under marketing review, and nearly 20 projects are about to initiate or are progressing through clinical trials. Through a dual-engine innovation approach combining collaborative development and in-house R&D, the Group continuously enriches its innovative pipeline centered on first-in-class (FIC) and best-in-class (BIC) products, efficiently advancing clinical development and commercialization. Moving forward, CMS will remain clinical needs-driven to deliver more quality pharmaceutical solutions, steadfastly advancing toward the goal of becoming a specialty-focused, innovation-excellent multinational pharmaceutical enterprise. About CMS CMS is a platform company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, dedicated to providing competitive products and services to meet unmet medical needs. CMS focuses on the global first-in-class (FIC) and best-in-class (BIC) innovative products, and efficiently promotes the clinical research, development and commercialization of innovative products, enabling the continuous transformation of scientific research into clinical practices to benefit patients. CMS deeply engages in several specialty therapeutic fields, and has developed proven commercialization capabilities, extensive networks and expert resources, resulting in leading academic and market positions for its major marketed products. CMS continues to promote the in-depth development in its advantageous specialty fields, strengthening the competitiveness of the Cardiovascular-Kidney-Metabolic/ gastroenterology/ ophthalmology/ skin health businesses, bringing economies of scale in specialty fields. Among them, the skin health business (Dermavon) has become a leading enterprise in its field, and is proposed to be listed independently on the SEHK. Meanwhile, CMS continuously promotes the operation and development of its integrated R&D, manufacturing and commercialization chain in Southeast Asia and the Middle East, capturing growth opportunities in emerging markets to support the high-quality and sustainable development of the Group. Reference 1. ZhangL, WangF, WangL, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey[J]. Lancet, 2012, 379(9818):815-822. DOI: 10.1016/S0140-6736(12)60033-6 2. Chinese Expert Consensus on the Diagnosis and Treatment of Renal Anemia (2014 Revised Edition)[J]. Chinese Journal of Nephrology, 2014, 30(9): 712-716. DOI: 10.3760/cma.j.issn.1001-7097.2014.09.015 3. 19th CSN Critical Care & Blood Purification Congress, Chinese Medical Association (July 2-5, 2025) 4. Chinese Expert Consensus on the Diagnosis and Treatment of Renal Anemia (2018 Revised Edition)[J]. Chinese Journal of Nephrology, 2018, 34(11): 860-866. DOI: 10.3760/cma.j.issn.1001-7097.2018.11.012 CMS Disclaimer and Forward-Looking Statements This press release is not intended to promote any products to you and is not for advertising purposes. This press release does not recommend any drugs, medical devices and/or indications. If you want to know more about the diagnosis and treatment of specific diseases, please follow the opinions or guidance of your doctor or other medical and health professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert. This press release which has been prepared by CMS does not constitute any offer or invitation to purchase or subscribe for any securities, and shall not form the basis for or be relied on in connection with any contract or binding commitment whatsoever. This press release has been prepared by CMS based on information and data which it considers reliable, but CMS makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this press release. Certain matters discussed in this press release may contain statements regarding the Group’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. Any forward-looking statements and projections made by third parties included in this press release are not adopted by the Group and the Company is not responsible for such third-party statements and projections. Media ContactBrand: China Medical System Holdings Ltd.Contact: CMS Investor RelationsWebsite: https://web.cms.net.cn/en/home/ Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
China Lilang Announces 2025 Annual Results ACN Newswire

China Lilang Announces 2025 Annual Results

HONG KONG, Mar 16, 2026 - (ACN Newswire via SeaPRwire.com) – China Lilang Limited (“China Lilang” or the “Company”, together with its subsidiaries, the “Group”; stock code: 1234) today announced its results for the year 2025.Mr. Wang Dong Xing, Chairman and Non-Executive Director of China Lilang, said: “In 2025, against a backdrop of steady macroeconomic recovery and moderate growth in the consumer market, the apparel industry in the Chinese Mainland maintained an overall stable development trajectory despite facing pressure. Amid the broader trend of consumption upgrading, the menswear market is undergoing structural differentiation, with mid-to-high-end segments such as business casual and smart casual becoming core growth drivers. The industry is accelerating its transition from 'quantity-driven competition' towards a stage of high-quality competition centered on 'innovation, quality and sustainable development. China Lilang deepened its presence in the menswear market with its differentiated brand matrix, building a diversified business portfolio through the 'LILANZ' core collection, the 'LESS IS MORE' smart casual collection and the 'MUNSINGWEAR' sports line, to comprehensively meet market demand for high-quality, diverse apparel. At the same time, the Group optimized its omni-channel marketing layout, strengthened online-offline operational synergies, actively expanded into emerging online platforms while accelerating the DTC model offline, and simultaneously advanced its internationalization strategy to enhance brand influence and operational efficiency across multiple dimensions.”During the year, the Group's revenue increased by 11.5% year-on-year to RMB4.07 billion. Revenue from the smart casual and other collections surged by 28.4%, primarily driven by a significant increase in average sales per store and the outstanding performance of new retail channels. Revenue from the core collection grew by 6.0%, mainly due to the initial operational efficiencies generated during the year following the Group's transition to a DTC model after reclaiming distribution rights from distributors starting last year.Gross profit margin increased by 1.9 percentage points year-on-year to 49.6%, mainly due to the increase in average unit price as a result of a higher proportion of direct-to-retail sales, coupled with a smaller one-off deduction from revenue arising from the recovery of distribution rights. Profit attributable to equity shareholders was RMB502 million (2024: RMB460 million), representing an increase of 9.0%. The profit margin attributable to equity shareholders decreased by 0.3 percentage points year-on-year to 12.6%. Earnings per share increased by 9.0% to RMB41.96 cents.The Board has recommended a final dividend of HK13 cents per share (2024: HK9 cents) and a special final dividend of HK3 cents per share (2024: HK3 cents). Together with the interim dividend already paid, the total dividend for the year amounted to HK32 cents per share, maintaining a stable dividend payout ratio.During the year, the Group adhered to its core strategy of ensuring a well-differentiated brand matrix and deepening its presence in the menswear market. The "LILANZ" core collection continued to consolidate its competitive advantage in the traditional menswear market. By optimizing product structure and deepening regional channel deployment and penetration, it further enhanced brand awareness and market share in key markets. Having successfully completed the repurchase and transformation of distribution rights in Northeast China and Jiangsu Province last year, the Group accelerated channel innovation throughout the year, subsequently acquiring the operating rights of first-tier distributors in Shandong Province and Chongqing City. The "LESS IS MORE" smart casual collection, targeting younger consumers, continued to operate under a fully direct-to-retail model, with its store opening strategy focused on shopping malls, which is preferred by consumers to enhance the consumer experience through a precisely tailored store image. As at the end of December 2025, there were 2,446 stores for the core collection and 371 stores for the smart casual and other collections, a total of 2,817 stores with a net increase of 44 stores.During the year, the Group continued to focus on opening stores in prime locations within premium shopping malls and outlet centers, attracting customers and boosting sales through distinctive brand-specific renovations. As at 31 December 2025, the number of stores located in shopping malls and outlet stores increased to 1,135 (31 December 2024: 1,036).The Group completed strategic transformation of its new retail business, upgrading it from an inventory clearance channel into a major new product sales platform. Revenue from this segment recorded a significant increase of 25% during the year. While continuing to strengthen its presence on mature sales platforms like Tmall, JD.com and TikTok, the Group has also expanded into emerging channels such as Pinduoduo, Wechat Channels and Poizon, creating a diversified online sales network altogether. The Group made full use of social platforms such as Xiaohongshu and Weibo to continuously produce high-quality content to strengthen its content-driven e-commerce strategy. This approach not only deepened the emotional connection with consumers but also effectively expanded the young customer base, opening new growth opportunities for the new retail business.Regarding the "Multi-brands and Internationalization" development strategy, the premium golf apparel brand "MUNSINGWEAR", a key element of the Group's multi-brand strategy, successfully completed its transaction closing in the first half of the year. In the second half, it opened its first batch of physical stores in locations including Chongqing and Jinjiang, further enriching the Group's diversified brand portfolio and premium product lines. Meanwhile, the Group's plan to open its first store in Malaysia was successfully implemented and the first stores commissioned in May. In November, it opened the world's first "Future Retail" concept flagship store at Pavilion Bukit Jalil, a core business district in Kuala Lumpur. By the end of December 2025, 4 stores had been opened. The smooth operation of all stores not only completed the initial layout in the Southeast Asian market but also laid an important foundation for the Group’s subsequent expansion across the region.During the year, the Group adhered to its core design philosophy of "Simplicity but Not Simple", deepening proprietary research and development across its industrial chain. It implemented a core premium product strategy, focusing on fabric innovation, craftsmanship upgrades and standard-setting to strengthen its competitive advantage of "Technology-Empowered Products", while transforming its technological expertise into industry-wide reference standards.Facing a market environment where opportunities and challenges coexist, China Lilang will maintain a prudent yet optimistic stance and continue to pursue its core strategy of "Multi-brands and Internationalization". It will advance channel reforms, strengthen product innovation and enhance operational efficiency, to bolster its leading position in China's menswear industry. The Group plans for a net increase of approximately 50 to 100 stores in 2026, with the focus remaining on premium shopping malls and outlets. At the same time, the Group will further consolidate the operating results of the regions that have transitioned and explore the possibility of rolling out the DTC model in other suitable regions to deepen market control and elevate consumer experience.In the new retail business, the Group will continue to advance its online channel layout, aiming to achieve over 15% growth in new retail sales in 2026. Through content-focused e-commerce and targeted live streaming, the Group seeks to reach more young customers and drive overall sales growth of 10%.The Group will steadily advance the business development of "MUNSINGWEAR", planning to continue expanding its physical store network in the Chinese Mainland and expanding its online sales channels to achieve online-offline synergy. In terms of international expansion, following its successful entry into the Malaysian market, the Group's company registration process in the Philippines has been completed, with business operations expected to officially commence in 2026, gradually refining its overseas channel layout.Mr. Wang Dong Xing, Chairman of China Lilang, concluded: “Looking ahead to 2026, the global geopolitical landscape remains complex and volatile, but the Chinese government continues to introduce policies and measures to promote consumption and expand domestic demand, providing support for the domestic market. Building upon the solid foundation established in 2025, China Lilang will focus on the development of its 'LILANZ' core collection and 'LESS IS MORE' smart casual collection, while deepening its new retail strategy and advancing multi-brand and overseas businesses, enabling it to advance towards a new stage of growth characterized by improvements in both quality and efficiency. It will also continue to drive R&D innovation and strength its ESG initiatives, achieving concurrent business growth and sustainable development, striving to create stable and sustainable returns for shareholders."About China LilangChina Lilang is one of the leading PRC menswear enterprises. As an integrated fashion enterprise, the Group designs, sources and manufactures high-quality business and casual apparel for men and sells under brands of 'LILANZ' and 'LESS IS MORE' across an extensive distribution network, mainly in the PRC and overseas. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
中国利郎公布二零二五年全年业绩 ACN Newswire

中国利郎公布二零二五年全年业绩

香港, 2026年3月16日 - (亚太商讯 via SeaPRwire.com) - 中国利郎有限公司("中国利郎"或"公司",及其附属公司,统称"集团";股份编号:1234)今天公布其二零二五年全年业绩。中国利郎主席兼非执行董事王冬星先生说:"二零二五年,中国内地服装行业在宏观经济稳步复苏与消费市场温和增长的背景下,整体保持基本稳定、承压前行的发展态势。男装市场在消费升级大趋势下呈现结构性分化,商务休闲、轻商务等中高端细分赛道成为增长核心动力,行业正加速从'数量竞争'迈向以'创新、品质与可持续发展'为核心的高质量竞争阶段。中国利郎以差异化品牌矩阵深耕男装市场,通过'利郎 LILANZ'主系列、'利郎 LESS IS MORE'轻商务系列及'万星威 MUNSINGWEAR'运动线构建多元业务布局,全方位满足市场高品质、多元化的消费需求。同时,集团优化全渠道营销布局,强化线上线下协同营运,线上积极拓展新兴平台、线下加速推动DTC模式,同步推进国际化布局,多维度提升品牌影响力与营运效能。"年内,集团收入同比增长11.5%至人民币40.7亿元。其中,轻商务及其他系列收入大幅上升28.4%,主要得益于单店平均销售额的大幅提升以及新零售渠道的突出表现。主系列收入增长6.0%,主要由于集团自去年起从分销商收回分销权转以DTC模式经营后,于年内初步产生经营效益。毛利率为49.6%,同比上升1.9个百分点,主要因为直营销售占比上升提高平均单价,加上因收回分销权产生的一次性收入扣除有所减少所致。权益股东应占利润为人民币5.0亿元(二零二四年:人民币4.6亿元),同比上升9.0%。股东应占利润率为12.3%,同比下降0.3个百分点。每股盈利同比上升9.0%至人民币41.96分。董事会建议派发末期股息每股13港仙(二零二四年:9港仙)及特别末期股息每股3港仙(二零二四年:3港仙),连同已派发的中期股息,全年每股派息合共32港仙,维持稳定的派息比率。集团于年内以差异化品牌矩阵为核心战略,深耕男装市场。"利郎 LILANZ"主系列持续巩固传统男装市场的竞争壁垒,透过优化产品结构、深化区域渠道布局与渗透,进一步提升品牌在核心市场的认知度与市场份额。继去年完成东北地区及江苏省的分销权回购转制后,集团于年内加速推进渠道革新,再完成收回山东省及重庆市一级分销商的经营权。针对年轻消费者的"利郎 LESS IS MORE"轻商务系列继续以全直营模式经营,开店策略集中在消费者偏好的购物中心,以精准的门店形象提升消费体验。截至二零二五年十二月底,主系列门店共2,446家,轻商务及其他系列门店371家,整体共2,817家门店,净增加44家。年内,集团继续集中在优质购物中心中的优越铺位和奥特莱斯开店,通过最具品牌个性的装修吸引顾客,提升销售。于二零二五年十二月三十一日,购物中心店及奥特莱斯店增加至1,135家(二零二四年十二月三十一日:1,036家)。集团新零售业务完成战略转型,从过往的库存清理渠道升级为主力新品销售平台,年内收入录得25%的显著增长。集团持续深耕天猫、京东、抖音等成熟销售平台的同时,拓展了拼多多、微信视频号、得物等新兴渠道,形成多元化线上销售网络。集团同时利用小红书、微博等社交平台,持续输出高品质内容,强化内容电商布局,不仅深化了与消费者的情感联结,更有效拓展了年轻客群,为新零售业务打开新的增长空间。「多品牌、国际化」发展战略方面,高端高尔夫服饰品牌"万星威 MUNSINGWEAR"作为集团多品牌战略的关键布局,上半年完成交易交割后,下半年在重庆及晋江等地开设首批实体门店,进一步丰富了集团的多元化品牌组合与高端产品线。而集团在马来西亚开设首家门店的计划顺利落实,并于五月份顺利试业。十一月于吉隆坡核心商圈Pavilion Bukit Jalil开设全球首家"未来商业(Future Retail)"概念旗舰店。于二零二五年十二月底已经开设4家门店,所有门店的顺利营运,不仅完成了东南亚市场的初步布局,更为集团后续辐射东南亚市场奠下重要基础。年内,集团贯彻"简约不简单"的设计核心,深化全产业链自主研发,打造核心精品单品战略,专注面料创新、工艺升级与标准制定,加强"技术赋能产品"的竞争优势的同时更将自身技术积累转化为全行业可参照的规范标准。面对机遇与挑战并存的市场环境,中国利郎将保持审慎乐观的态度,继续深耕"多品牌、国际化"核心战略,推进渠道改革、强化产品创新、提升运营效率,巩固并提升集团于中国男装行业的领先地位。集团计划于二零二六年全年净增加约50至100家门店,开店重点继续聚焦于优质购物中心及奥特莱斯。同时,集团将进一步巩固已转型区域的经营成果,并探索在更多合适区域推广DTC模式,以强化市场控制力、提升消费体验。新零售业务方面,集团将持续推进线上渠道布局,目标二零二六年实现新零售销售额增长15%以上,并通过内容电商与精准直播触达更多年轻客群,带动整体销售实现10%增长。集团将稳步推进"万星威 MUNSINGWEAR"的业务发展,计划在中国内地继续拓展实体门店网络,并拓展线上销售渠道,实现线上线下联动。国际化拓展方面,继马来西亚市场后,集团在菲律宾的公司注册程序已完成,预计于二零二六年内正式开展业务,逐步完善海外渠道布局。王冬星主席总结说:"展望二零二六年,全球地缘政治格局依然复杂多变,但中国政府持续推出促进消费、扩大内需的政策措施,为国内市场提供支撑。中国利郎将立足于二零二五年所奠定的稳健基础,在聚焦'利郎 LILANZ'主系列及'利郎LESS IS MORE'轻商务发展的同时,深化新零售战略,推进多品牌及海外业务,从而向质量与效率双升的高阶增长阶段迈进,并将继续透过研发创新,持续加强 ESG 建设,实现业务增长与可持续发展并行,致力为股东创造稳健及可持续的回报。"关于中国利郎中国利郎是中国领先的男装企业之一。作为一家综合时装企业,集团设计、采购、生产并以品牌"利郎LILANZ"及"利郎LESS IS MORE"销售优质男士商务及休闲服装。其产品主要于中国及海外的广阔零售及分销网络销售。 Copyright 2026 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
Fujitsu Japan and Teikyo University Hospital launch joint proof of concept to build mechanism for data analysis and referred-patient management JCN Newswire

Fujitsu Japan and Teikyo University Hospital launch joint proof of concept to build mechanism for data analysis and referred-patient management

Kawasaki and Tokyo, Japan, Mar 16, 2026 - (JCN Newswire via SeaPRwire.com) - Fujitsu Japan Limited and Teikyo University Hospital today announced the start of a joint proof of concept aimed at strengthening regional medical collaboration. The initiative, which commenced on March 16, focuses on developing new information analysis and patient management mechanisms utilizing medical administration systems and electronic health record data. This will facilitate the prompt admittance of severely ill patients requiring hospitalization or surgery and a smooth transition back to primary care after discharge.This joint experiment will implement the following initiatives for Teikyo University Hospital's regional medical collaboration operations:1. Digitalization of Patient Workflow from Referral Acceptance to Discharge CoordinationBy introducing AI-OCR and electronic paper for referral reception and discharge coordination, information from outside the hospital will be digitized. This will be seamlessly integrated with electronic health records and regional medical collaboration information systems, aiming to eliminate duplicate data entry and improve overall operational efficiency.2. Verification of the Health Care Management Platform for Data-Driven Strategic Patient AcquisitionBased on data from medical accounting systems and electronic health records, Health Care Management Platform, an offering under Fujitsu Limited's Uvance business model which addresses societal challenges, will be used to visualize and analyze trends in referred patients and collaborating facilities in a timely manner. This will enable the identification of facilities where collaboration should be strengthened, and actual visits to these facilities will be conducted to enhance regional collaboration. Visit records and results will be registered and accumulated in Salesforce's Agentforce 360 Platform, aiming to utilize this information for analyzing referral performance and formulating strategies that comprehensively address the needs of collaborating facilities.Figure: Patient workflow in regional medical collaboration and a joint proof of conceptThrough this initiative, Teikyo University Hospital aims to reduce the administrative workload of its Medical Collaboration Office, which handles regional collaboration tasks, by 30%, while contributing to the provision of high-quality and prompt medical care and the optimization of medical resources for patients.Moving forward, both parties will expand the scope of integration between this system and electronic health records to centrally manage the patient workflow, including treatment processes after referral acceptance. This will contribute to providing medical care to patients at more appropriate times and supporting decision-making for healthcare professionals, thereby improving hospital management and fostering regional medical collaboration.Fujitsu Japan will leverage the insights from this joint experiment to enhance accuracy and add new functionalities to its offerings, supporting Teikyo University Hospital's digital transformation (DX) and the promotion of digital hospitals. Furthermore, under Uvance, Fujitsu Japan will drive the transformation of medical practice workflows through data and AI, advancing the establishment of a sustainable healthcare delivery system.Teikyo University Hospital will systematize this mechanism as a model for realizing a data-driven regional healthcare system and promote its expansion to other medical institutions and regions. Through this initiative, the hospital also aims to further enhance the role and value of its Medical Collaboration Office, which serves as the hospital's public face, and build a foundation for the office to function as a hub for regional medical care, moving beyond its traditional role of handling referral reception and coordination.BackgroundJapanese healthcare faces a challenging management environment due to a declining birthrate, an aging population, and rising material costs, while medical needs are becoming increasingly complex due to advancements in medical technology. To ensure sustainable healthcare, it is essential to strengthen collaboration between primary care physicians and specialists, ensuring patients are referred at appropriate times, receive advanced treatment, and are then referred back to their primary care physicians for ongoing care. This kind of regional medical collaboration is essential.The Japanese government is also promoting medical DX and functional differentiation and collaboration within regions, establishing evaluations and incentives in the fiscal year 2026 medical fee revision.As a specialized hospital in the Itabashi Ward region, Teikyo University Hospital accepts over 30,000 referred patients annually and has actively promoted regional collaboration through continuous lectures and visits to medical institutions. Regarding referred patient acceptance, the hospital receives approximately 200 calls daily from patients and medical institutions, utilizing up to eight lines at a time. A key challenge has been the time and burden placed on reception staff to coordinate referred patient acceptance, especially for urgent referrals and transfer requests from other medical institutions, often requiring consultation with doctors, leading to waiting times for outpatient appointments and hospitalization.About FujitsuFujitsu’s purpose is to make the world more sustainable by building trust in society through innovation. As the digital transformation partner of choice for customers around the globe, our 113,000 employees work to resolve some of the greatest challenges facing humanity. Our range of services and solutions draw on five key technologies: AI, Computing, Networks, Data & Security, and Converging Technologies, which we bring together to deliver sustainability transformation. Fujitsu Limited (TSE:6702) reported consolidated revenues of 3.6 trillion yen (US$23 billion) for the fiscal year ended March 31, 2025 and remains the top digital services company in Japan by market share. Find out more: global.fujitsuPress ContactsFujitsu LimitedPublic and Investor Relations DivisionInquiries Copyright 2026 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com
More
2026年“中国品牌出海·全球行”(南美洲站)在巴西圣保罗拉开帷幕 Finance

2026年“中国品牌出海·全球行”(南美洲站)在巴西圣保罗拉开帷幕

(SeaPRwire) - 巴西圣保罗2026年3月15日电 -- 由《环球时报》主办的2026“中国品牌出海·全球行”(南美站)大型品牌推广活动于3月10日在巴西圣保罗举行。活动以“新质引领,品牌扬帆”为主题,汇聚了两国的外交使节和企业领袖,共同探讨该地区的可持续增长路径。 “此次活动不仅是中国品牌的集中展示,也是两国企业深化互信、谋求共同发展的宝贵机遇,”中国驻圣保罗总领事馆副总领事张曦表示。 环球时报在线(Huanqiu.com)副总经理、活动主办方代表李刘琛指出,该媒体通过多语言平台拥有全球3.3亿多用户,为寻求与国际市场真诚互动的中国品牌搭建了桥梁。 中国国际贸易促进委员会(CCPIT)巴西代表处首席代表、巴西中国企业协会秘书长李东成强调:“中国品牌需要通过培育本地供应链和深入了解消费者心理,在这个市场扎根。”他还推广了第四届中国国际供应链博览会(CISCE)。 中国品牌与市场的深化联系以中国最具历史的白酒生产商之一汾酒为例。山西杏花村汾酒国际贸易有限公司副总经理杨耀杰在视频致辞中强调了公司与美洲长达一个世纪的联系。活动上举行了汾酒巴西新产品线的发布仪式,为与会者提供了沉浸式的中国白酒文化体验。 活动通过视频展示和现场展览推广了北京通州。 巴西与会者、ZIRAN首席执行官阿德马尔·佩雷拉(Admar Pereira)表示,他期待更多中国品牌进入市场,并希望它们加深对当地消费者需求的理解。 由《环球时报》主办、Huanqiu.com承办、Fenjiu International联合主办、巴西中国企业协会支持的“中国品牌出海·全球行”旨在促进中国品牌与全球市场之间“开放务实”的交流。 公司:Global Times Online 联系人:秦静 邮箱:qinjing@huanqiu.com 网站:www.huanqiu.com 城市:北京 本公告附带的照片可在以下网址获取: https://www.globenewswire.com/NewsRoom/AttachmentNg/e746ff2a-5f4e-4e12-b10f-a8b6bcc22a02 https://www.globenewswire.com/NewsRoom/AttachmentNg/62977691-24d1-465a-84ff-df80b8ebbc8a https://www.globenewswire.com/NewsRoom/AttachmentNg/26b76ad6-65b1-44a2-a812-15890e6fb6bd本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布,覆盖超过6,500个媒体库、86,000名编辑和记者,以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。
More
2026“Chinese Brands Going Global · Worldwide Tour”(南美站)在巴西圣保罗启动 Finance

2026“Chinese Brands Going Global · Worldwide Tour”(南美站)在巴西圣保罗启动

(SeaPRwire) - 圣保罗,2026年3月15日——由《环球时报》主办的2026“中国品牌出海·全球行”(南美站)大型品牌推广活动于3月10日在巴西圣保罗举办。活动以“新质引领,品牌扬帆”为主题,汇聚了两国的外交使节和商界领袖,共同探讨该地区的可持续增长路径。 “此次活动不仅是中国品牌的集中展示,也是两国企业深化互信、寻求共同发展的宝贵机会,”中国驻圣保罗总领事馆副总领事张曦表示。 《环球时报》在线(环球网)副总经理、活动主办方代表李柳申指出,该媒体通过多语言平台拥有全球超过3.3亿用户,是中国品牌寻求与国际市场真诚互动的桥梁搭建者。 中国国际贸易促进委员会(CCPIT)驻巴西代表处首席代表、巴西中国企业协会秘书长李东成强调:“中国品牌需要通过培育本地供应链和深入了解消费者心理,在这个市场扎根。”他还推介了第四届中国国际供应链博览会(CISCE)。 中国品牌与市场的深度联结以中国最具历史的白酒生产商之一汾酒为例。山西杏花村汾酒国际贸易有限公司副总经理杨耀杰在视频致辞中强调了公司与美洲长达一个世纪的联系。活动上举行了汾酒巴西新产品线的启动仪式,为与会者提供了沉浸式的中国白酒文化体验。 活动通过视频展示和现场展览推介了北京通州。 巴西参会者、ZIRAN首席执行官阿德马尔·佩雷拉(Admar Pereira)表示,他期待更多中国品牌进入市场,并希望它们加深对当地消费者需求的理解。 由《环球时报》主办、环球网承办、汾酒国际联合主办、巴西中国企业协会支持的“中国品牌出海·全球行”旨在促进中国品牌与全球市场之间“开放务实”的交流。 公司:Global Times Online 联系人:秦静 电子邮件:qinjing@huanqiu.com 网站:www.huanqiu.com 城市:北京 本公告附带的照片可在以下链接获取: https://www.globenewswire.com/NewsRoom/AttachmentNg/e746ff2a-5f4e-4e12-b10f-a8b6bcc22a02 https://www.globenewswire.com/NewsRoom/AttachmentNg/62977691-24d1-465a-84ff-df80b8ebbc8a https://www.globenewswire.com/NewsRoom/AttachmentNg/26b76ad6-65b1-44a2-a812-15890e6fb6bd本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布,覆盖超过6,500个媒体库、86,000名编辑和记者,以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。
More

Accelerated Technology Commercialization Drives High-Growth Performance, Qunabox Group Leads the AI Interactive Marketing Track

HONG KONG, Mar 16, 2026 - (ACN Newswire via SeaPRwire.com) – As the integration of artificial intelligence technology with physical consumption scenarios enters a deeper stage, a dual revolution in business efficiency and consumer experience is unfolding. As a leader in China’s AI interactive marketing services sector, Qunabox Group (00917.HK) has achieved both rapid performance growth and a turnaround to profitability by leveraging its innovative business model of "technology middleware platform + multi-business synergy + global scenario deployment", setting a new benchmark for the digital transformation of the industry.AI-Powered Marketing Services, Building a Dual-Engine Model of "Technology + Data"At the core of Qunabox Group’s business model is the creation of a technology-driven, end-to-end value closed loop that upgrades AI from a single functional tool to a core engine embedded throughout the entire consumer journey. Marketing services, as the Group’s core business segment, has developed a dual-engine model of "standardization + value-added services", which continuously optimizes revenue quality and gross profit structure.In terms of service model, the Group has deeply covered key consumer sectors such as food and beverages, daily necessities, new energy vehicles and household appliances. With a high-quality, stable and diversified brand customer base as its foundation, the Group keeps deepening cooperation with major clients by expanding service scenarios and optimizing product portfolio, thus achieving simultaneous growth in both the number of clients and the value generated per client.In terms of product innovation, the Group takes technological R&D as the key driver, enabling AI to act as the "execution agent" throughout the end-to-end marketing value chain. The upgraded AI digital human shopping assistant, equipped with cross-sensory intent recognition and high-precision 3D modeling, delivers precise personalized recommendations and elevates user experience. The newly launched AI holographic marketing cabinet creates immersive display scenarios for high-intelligence products, restructuring the interaction mode of offline marketing. Meanwhile, the AI Agent marketing workstation enables closed-loop management across the entire process from content planning to performance tracking, raising marketing execution efficiency and precision to a new level.In the meantime, the implementation of the AIGC marketing resource library and the marketing selling points database for beverages and snack foods has made data value the core support for marketing decision-making, forming a new marketing service model driven by the dual wheels of "technology + data" and further consolidating the Group’s leading position in the field of AI interactive marketing.Global Layout in Innovative Tracks, R&D Innovation to Build Solid BarriersLifestyle and innovative businesses have injected long-term growth momentum into the Group’s business model. Focusing on "AI + Lifestyle", the Group has proactively explored emerging markets, with key focus on the Middle East, Southeast Asia and Australia where the demand for high-quality technology-enabled experiential consumption is robust. An overseas business department has been established to achieve end-to-end localized operation and management. At present, the AI indoor entertainment space has completed preliminary preparation and successfully obtained relevant business licenses in Dubai and Singapore.From the validation of localized models to the integration of software and hardware systems, and from the building of professional teams to the development of content ecosystem, the Group has realized cross-cultural and multilingual adaptation of its AI technologies through refined operation and management. This has allowed its "AI + consumption scenarios" business model to expand beyond domestic markets, providing innovative solutions for the upgrading of global consumer markets.In addition, other service businesses including IT system development leverage the Group’s technological reserves and first-mover advantages in AI applications to undertake technology development demands from industrial clients. These businesses have become an important extension of the commercialization of the Group’s technological capabilities, further enriching the Group’s revenue structure.In building technological barriers, Qunabox Group deeply integrates R&D innovation with intellectual property protection. The number of software copyrights registered in China and patents held by the Group has increased to 173 and 22 respectively, with an additional 133 patents currently under application, making technological innovation a solid guarantee for the sustainable development of the Group’s business model.At present, the integration of artificial intelligence and physical consumption is entering a phase of accelerated large-scale implementation. With its business model centered on "AI + Consumption Scenarios", Qunabox Group has not only achieved high-quality development for itself, but also reshaped the value creation model of the consumer industry.Looking ahead, Qunabox Group will continue to deepen its technological advantages and service capabilities, advance strategic industrial mergers and acquisitions, and optimize its AI-powered experiential consumption business model. By leveraging the synergy of new technologies, new scenarios and new markets, the Group aims to build a cross-regional, end-to-end AI lifestyle platform. It will keep driving industry innovation and progress, creating commercial value for brand clients, delivering new experiences for consumers, and generating long-term value for shareholders and society. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More

InnoCare 宣布在中国新型 VAV1 降解剂 ICP-538 的临床试验中,首位健康志愿者完成给药

(SeaPRwire) - 北京,2026年3月15日 -- 专注于癌症和自身免疫性疾病治疗领域的领先生物制药企业InnoCare Pharma(港交所代码:09969;上交所代码:688428)今日宣布,其VAV1靶向分子胶降解剂(MGD)ICP-538的临床试验在中国完成首例健康受试者给药。这是中国首款、全球第二款获批进入临床试验的VAV1降解剂。 ICP-538是一款新型、强效、高选择性的口服VAV1靶向分子胶降解剂,VAV1是T细胞和B细胞受体下游的关键蛋白。ICP-538通过选择性介导CRBN E3泛素连接酶与VAV1蛋白形成三元复合物,以剂量依赖的方式诱导VAV1蛋白快速、高效降解。ICP-538将被开发用于治疗炎症性肠病、系统性红斑狼疮、多发性硬化症等自身免疫性疾病。目前全球范围内尚无获批的VAV1靶向疗法。 降解VAV1可有效抑制T细胞的增殖、分化、活化及细胞因子释放,同时抑制B细胞活化及细胞因子释放,从而发挥抗炎和免疫调节作用,缓解自身免疫和炎症病理进程。临床前研究显示,ICP-538可诱导VAV1深度降解,使免疫介导疾病相关的细胞因子显著减少,且对其他蛋白未产生可检测到的影响。 InnoCare联合创始人、董事长兼首席执行官崔霁松博士(Dr. Jasmine Cui)表示:“我们致力于开发自身免疫性疾病领域的创新药物。作为一种新型疗法,VAV1分子胶降解剂具备三大核心优势:靶点选择性高、可介导多重作用机制、疗效出色。我们很高兴能够快速推进临床开发,相信ICP-538将为自身免疫性疾病患者提供更优的治疗选择。” 关于InnoCare InnoCare是一家处于商业化阶段的生物制药企业,致力于为中国及全球存在未被满足医疗需求的癌症和自身免疫性疾病患者发现、开发并商业化首创及/或同类最优药物。InnoCare在北京、南京、上海、广州、香港及美国均设有分支机构。 InnoCare前瞻性声明 本报告包含部分前瞻性声明披露内容。除事实陈述外,所有其他陈述均可被视为前瞻性声明,即与我方或我方管理层对未来将会或可能发生的事项的意图、计划、信念或预期相关的陈述。此类陈述是我方管理层基于其对历史趋势、当前状况、预期未来发展及其他相关因素的经验和认知做出的假设和估算。该等前瞻性声明不保证未来业绩,实际结果、发展进程及商业决策可能与前瞻性声明的预期不符。我方的前瞻性声明还受到大量风险和不确定因素的影响,这些风险和不确定性可能会影响我方的短期和长期业绩表现。本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布,覆盖超过6,500个媒体库、86,000名编辑和记者,以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。 联系方式 媒体咨询投资者咨询卢春华(Chunhua Lu) 86-10-6660987986-10-66609999chunhua.lu@innocarepharma.comir@innocarepharma.com
More
FWD Group delivers record full year 2025 results with profitable growth, improved capital and cash flow generation JCN Newswire

FWD Group delivers record full year 2025 results with profitable growth, improved capital and cash flow generation

HONG KONG, Mar 16, 2026 - (ACN Newswire via SeaPRwire.com) – FWD Group Holdings Limited (“FWD Group” or “FWD”) today announced its first set of full-year results as a Hong Kong listed company for the 12 months ended 31 December 2025.- New business sales were up 25 per cent to US$2.446 billion compared to 2024 on an annualised premium equivalent (APE) basis. New business contractual service margin (CSM) was US$1.476 billion, with year-on-year growth of 18 per cent.- Operating profit after tax was up five per cent to US$499 million with positive contributions from each of the company’s four geographic reporting segments – Hong Kong SAR & Macau SAR; Thailand & Cambodia; Japan; and Emerging Markets.- Net profit of US$166 million is a record IFRS 17 result and for the second consecutive year, FWD Group was operating cash flow positive as at 31 December 2025. Leverage ratio reduced to 21.3 per cent approaching the company’s target range of 15-20 per cent.- Significantly increased important indicators of shareholder value creation, with comprehensive tangible equity (CTE) up 18 per cent to US$8.72 billion compared to 31 December 2024 and Group embedded value (EV) up 19 per cent year-on-year to US$6.85 billion. A strong capital position was maintained with a 265 per cent solvency ratio^.- In December 2025, FWD Group was added to the Hang Seng Composite Index and the eligible securities list for the Stock Connect programme, where Mainland Chinese investors connect via the Shanghai Stock Exchange and Shenzhen Stock Exchange with Hong Kong market opportunities via a southbound trading mechanism. FWD Group was also included in the MSCI Hong Kong Small Cap Index in February 2026.Huynh Thanh Phong, Group Chief Executive Officer and Executive Director of FWD Group, said, “2025 was a stand-out year for FWD Group. We successfully executed our customer-led strategy, underpinned by our digitally enabled business model. Record financial results were achieved. And of course, we began trading as a publicly listed company, following our July 2025 initial public offering. This fulfilled a long-held objective to ensure FWD Group has full capital market access, as a solid foundation for our future development and growth.”The strong 2025 results were driven by organic growth across most of the 10 Asian markets where FWD Group operates, with a particularly outstanding performance in the Hong Kong SAR & Macau SAR segment.A solid performance was posted in Japan, in a year where FWD began to diversify beyond its successful protection business into the retirement and savings segment, with its first offering – a yen-denominated single premium variable annuity product.As an established market leader in Thailand, FWD remains well positioned to grow quality new business in future, despite headwinds from a lower rate environment which impacted 2025 results, in addition to the 2024 exit from underwriting new business in the corporate care segment.Excellent growth was delivered in the Emerging Markets segment – which is comprised of five of the rest of FWD Group’s Southeast Asian markets – consistent with the longer-term demographic, wealth creation, and digital adoption trends in this region.“With 2026 already underway, we remain firmly focused on executing our strategy as we build for the future – operating with customers at the heart of everything we do in high-growth Asian markets, with a focus on long-term sustainability and profitability,” added Huynh Thanh Phong.About FWD GroupFWD Group (1828.HK) is a pan-Asian life and health insurance business that serves more than 38 million customers across 10 markets, including BRI Life in Indonesia. FWD’s customer-led and tech-enabled approach aims to deliver innovative propositions, easy-to-understand products and a simpler insurance experience. Established in 2013, the company operates in some of the fastest-growing insurance markets in the world with a vision of changing the way people feel about insurance. FWD Group is listed on the main board of the Hong Kong Stock Exchange under the stock code 1828.For more information, please visit www.fwd.comFor media inquiries, please contact: groupcommunications@fwd.comSource: FWD Group Holdings LimitedThe results are for the 12 months ended 31 December 2025 and are compared to the same period in 2024.Group LCSM cover ratio, group embedded value, comprehensive tangible equity values are December 2025 balances/ratios and growth rates are represented accordingly.Growth rates are represented on a constant exchange rate (CER) basis, unless otherwise stated.Except for operating profit/(loss) after tax (non-IFRS measure), net profit/(loss), and comprehensive tangible equity, all other numbers are unaudited. Operating profit after tax and net profit after tax represent the amounts attributable to equity holders of the company and are presented net of non-controlling interests. New business sales are calculated on an annualised premium equivalent (APE) basis, based on 100 percent annualised first year premiums and 10 percent single premiums. Comprehensive tangible equity is calculated as total equity of the Group attributable to shareholders of the Company plus contractual service margin (net of tax and non-controlling interests), minus intangible assets (net of non-controlling interests).* Actual exchange rate basis ^ Prescribed capital requirement (PCR) basis Copyright 2026 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com
More

中石化炼化工程发布2025年年度业绩 首次启动特别股息分配 全年实际派息率达88% 新签订单连续第二年站稳千亿规模

EQS via SeaPRwire.com / 2026-03-15 / 21:59 UTC+8 新闻稿 (请即时发布) (股份代号:2386) 中石化炼化工程发布2025年年度业绩 首次启动特别股息分配 全年实际派息率达88% 新签订单连续第二年站稳千亿规模 (2026年3月16日,香港)中石化炼化工程(集团)股份有限公司(「中石化炼化工程」或「本公司」,连同其附属公司合称「集团」)(股份代号:2386)今日公布截至2025年12月31日止十二个月(「报告期」)的年度业绩。 2025年,面对全球能源格局深刻调整、行业竞争日趋激烈的挑战,本集团坚持以高质量发展统揽全局,以更加开放的姿态推进国际化经营,以更加坚定的决心推进科技创新,以更加务实的举措回报股东信任,交出了一份成色十足的年度答卷。 2025年,实现营业收入人民币700.74亿元、净利润人民币18.07亿元。董事会始终坚持「以投资者为本」的核心理念,坚持以高股息政策与全体股东共享高质量发展成果。建议派发末期股息每股人民币0.104元,全年基础派息率65%;为进一步彰显对长远发展的坚定信心、保障股东回报,本公司首次启动特别股息分配,建议增派特别股息每股人民币0.094元,合并末期股息后合计派发每股人民币0.198元。计入已派发的中期股息,全年合计每股人民币0.358元,实际派息率88%,派息规模与上年保持平稳。。 生产经营质效稳步提升,发展韧性持续增强。 市场规模稳中有进。全年新签订单人民币1,012.48亿元,连续第二年站稳千亿规模,呈现出总量稳步攀升、结构持续优化、业务加速向前端延伸的良好态势。国际化经营提质提速,初步构建起系统内、系统外、境外市场各占三分之一的多元均衡布局,抗风险能力显着增强。高端业务实现突破。高水平前端工程优势持续巩固,成功签署沙特ACWA大型绿氢项目FEED+可转换EPC合同等一批标志性境外前端业务,旗下5家工程公司年内全部实现海外前端业务「零的突破」,源头竞争力全面提升。综合优势更加显着。「国际规则+中国效率」的独特竞争优势充分显现,综合工程服务能力获得全球客户高度认可。目前,前端类与EPC类在手订单占比超过80%,订单结构持续优化,有力带动收入结构不断优化,在激烈市场竞争中展现出强劲经营韧性,实现了质的有效提升和量的合理增长。 技术创新能力持续引领,新型工业化迈出坚实步伐。 技术创效稳中有进。全年签订技术开发和技术许可合同人民币10.13亿元,技术直接创效能力稳步增强。创新生态全面扩容。坚持「开放合作、集成创新」,深化与顶尖科研院所、高校「产学研」融合,携手海外业主与合作伙伴,推动优势技术「出海」;成功承办第十二届世界化学工程大会「流程工业创新与过程系统工程再造分会」,汇聚全球近200位化工领域专家学者、企业代表和行业精英参会交流。数智转型加速落地。发布《全面推进公司引领工程建设行业新型工业化工作体系指南》,在智能设计、机器代工、数字化交付等领域形成一批可复制、可推广的成果,工程建设模式加速向「标准精益设计+工厂化智造+装配化安装」转型升级。全域AI应用走向「实战」:设计端,知识图谱与生成式设计大幅赋能效率;管理端,全生命周期供应链智能管理体系与智慧工地建设同步推进;施工端,无导轨爬行焊机、多轴焊接机器人等智能装备广泛应用。 公司治理持续完善,上市公司质量稳步提升。 治理体系规范高效。圆满完成中国石油天然气集团有限公司持股转流通,股权结构和治理结构进一步优化;顺利完成公司章程系统性修订,董事会审计委员会全面承接监事会职能。产业布局实现拓展。注册成立中石化(广东)环境科技有限公司,打造专业化环境治理平台,助力呵护碧水蓝天净土;完成对华东管道设计研究院股权收购,管道储运设计领域综合实力进一步增强。ESG绩效持续领先。深入推进中国石化社会责任品牌建设,持续开展「沉浸式公共安全体验应急科普公益活动」,展现央企担当;万得ESG评级稳居AA级行业最高水平,连续两年荣获「中国上市公司ESG年度最佳实践奖」。 中石化炼化工程董事长蒋德军先生表示:本公司已编制完成《「十五五」发展规划纲要》并获得董事会审议通过。明确「价值引领、创新驱动、成本领先、数智赋能、绿色洁净、全球发展、融合共生」七大发展战略;完成「发展指标体系、境内市场开发、国际化经营、施工业务转型、科技创新、绿色低碳与节能环保、数智融合、智能制造」八大专项课题研究。到2030年,具备世界一流技术先导型工程公司的基本特征,成为科技实力雄厚、管理能力卓越、一体化协同发展、风险防控有效、整体价值显着提升的工程集团;到2035年,努力实现主营业务收入过千亿元,境外业务收入占比稳定在1/3以上,核心技术国际竞争力显着增强,品牌影响力稳居国际工程公司前列的远期目标。2026年,本集团将按照董事会决策部署,着力推进「强化战略引领和统筹一体化,持续推动创新驱动、精益管理、数智赋能、绿色低碳,高水平支撑能源化工产业转型升级,高标准引领工程建设行业新型工业化,高质效推进工程建设企业运营国际化,高效能实现上市公司价值创造多元化」等发展举措,在创建世界领先技术先导型工程公司道路上迈出更加坚实步伐。 业务回顾及经营重点 QHSE保持良好绩效 本报告期内,本集团在执行项目1,888个,现场日均用工约12万人。截至本报告期末,累计安全人工时3.59亿,未发生重大安全、质量、环保事故。 本报告期内,本集团全面开展安全标准化班组示范建设,持续推动班组长及分包商三类关键岗位人员持证上岗,并实现战略分包商培训全覆盖。聚焦设计、校核、变更等关键环节,组织开展质量提升专项行动,从源头有效降低HSE风险。积极推进智慧化工地建设,推广应用智能违章识别系统与电子围栏等先进技术装备。上线「危大工程」(1)作业监管平台,实施三级管控与全过程信息化动态监管,并建立问题数据库,强化风险闭环管理。深化「大健康」管理,开展「健康管理年」活动,搭建员工健康谘询服务平台。围绕「降碳、减污、提效、增绿」四大目标,启动绿色企业创建第二阶段行动,从设计源头落实节能减排措施,全面推行绿色施工,持续提升可持续发展能力。 注:(1) 危险性较大的分部分项工程 市场开发成果量质齐增 本报告期内,本集团新签订合同额为人民币1,012.48亿元。其中,境内新签订合同额约人民币632.48亿元;境外新签订合同量约54.29亿美元。 境内市场,本集团深耕战略客户,强化一体化推介,以整体解决方案持续提升市场份额。在稳固传统业务核心优势的同时,持续拓展新技术、新材料、新能源等业务。本报告期内,境内新签代表性合同包括中国石化茂名乙烯项目EPC总承包合同,合同金额总计约为人民币118.21亿元;中国石化洛阳百万吨乙烯项目(「洛阳乙烯项目」)EPC总承包合同,合同金额总计约为人民币65.53亿元;陕煤榆林化学1500万吨╱ 年煤炭分质清洁高效转化示范项目(「陕煤榆林煤化工项目」)EPC总承包合同,合同金额总计约为人民币27.72亿元;国能神华包头煤制烯烃升级示范项目MTO及烯烃分离装置(「神华包头MTO」)EPC总承包合同,合同金额总计约为人民币23.67亿元。 本报告期内,本集团在新兴业务领域中新签合同348个,新签合同额约人民币110亿元。其中,来自清洁能源及新能源领域合同40个,新签合同金额约为人民币18亿元;来自新材料、新技术、节能、环保等新兴领域合同308个,新签合同金额约为人民币92亿元。 境外市场,本集团加快打造更加多元、更趋均衡、更具韧性的全球市场网络。加大与国际同业伙伴强强联合,加强与战略客户的高层互访和推介交流。本报告期内,境外新签代表性合同包括阿尔及利亚哈西炼厂项目(「哈西炼厂项目」)EPC总承包合同,合同金额约为20.58亿美元;哈萨克斯坦斯坦Silleno石化综合体项目之聚乙烯及公用工程项目(「哈萨克斯坦斯坦Silleno PE & UIO项目」)EPC总承包合同,合同金额约19.02亿美元;沙特阿美Haradh GOSP-3油气分离增产项目(「沙特Haradh项目」)EPC总承包合同,合同额约7.07亿美元;阿尔及利亚奥兰阿尔泽炼厂重整项目(「阿尔泽炼厂项目」)EPCC总承包合同,合同额约4.33亿美元。 在前端工程领域,本集团签订了包括ACWA沙特延布绿氢绿氨FEED+可转化EPC、阿联酋NGL项目FEED+可转化EPC、NKNK乙苯苯乙烯技术转让及工艺包设计、哈萨克斯坦硫酸基础设计、越南生物质气化制航煤项目可行性研究、中国石化湖南石化岳阳地区100万吨╱ 年乙烯炼化一体化项目(「岳阳乙烯项目」)工程设计、中国石化齐鲁石化鲁油鲁炼转型升级技术改造项目(「齐鲁升级项目」)工程设计、神华榆林循环经济煤炭综合利用项目(「神华榆林煤化工项目」)工程设计等合同,持续迈向产业链前端和价值链高端。 本报告期内,本集团主要在执行项目情况: 北方华锦联合石化精细化工及原料工程项目(EPC):该项目已机械竣工,进入收尾阶段。 中沙石化福建古雷乙烯及下游深加工联合体项目 (EPC):该项目处于安装施工收尾阶段,总体进度逾九成。 茂名乙烯项目(EPC):该项目设计进入收尾阶段,施工进入安装阶段,总体进度近五成。 洛阳乙烯项目(EPC):该项目乙烯装置处于基础设计阶段,配套炼油装置处于施工安装阶段,总体进度近三成。 联泓格润(山东)新能源材料和生物可降解材料一体化项目(EPC):该项目已建成中交,转入投料试车。 中煤榆林煤炭深加工基地项目(EPC):该项目设计进入收尾阶段,施工进入安装阶段,总体进度近五成。 神华包头MTO(EPC):该项目处于详细设计阶段,施工进入土建阶段,总体进度逾三成。 沙特阿美Riyas NGL项目P1、P2标段(EPC):该项目设计进入收尾阶段,施工已进入安装高峰,总体进度逾六成。 沙特AMIRAL项目之罐区及与SATORP炼厂集成项目(EPC):该项目设计进入收尾阶段,施工进入安装高峰,总体进度逾六成。 沙特阿美Jafurah天然气扩建III期项目(EPC):该项目处于设计及采购高峰,施工已全面启动,总体进度逾四成。 沙特阿美原油输送泵站升级改造项目(EPC):该项目已基本完成,总体进度逾九成。 哈萨克斯坦Silleno项目:(1)乙烷裂解(ECU)项目(EPC)处于设计及采购阶段,施工已经启动,总体进度逾四成。(2)聚烯烃及公用工程(PE & UIO)项目(EPC)已开启设计和采购工作,总体进度逾一成。 阿尔及利亚哈西炼厂项目(EPC):该项目处于设计和采购高峰,施工进入准备阶段,总体进度逾二成。 阿尔及利亚LNG/MTBE(EPCC)项目:该项目设计、采购工作基本完成,处于施工高峰,总体进度逾八成。 沙特Haradh项目(EPC):该项目已开启设计和采购工作,总体进度逾一成。 阿联酋NGL项目(FEED):该项目总体设计工作已完工,进入EPC合同评标阶段。 沙特延布绿氢项目(FEED):该项目总体设计进度逾三成。 注:「FEED」指前端工程设计合同;「EPC」指设计、采购、施工总承包合同;「BEPC」指基础设计、详细设计、采购、施工总承包合同;「EPCC」指设计、采购、施工总承包、开车服务合同;「C」指施工总承包合同。 持续推进科技创新 本报告期内,本集团持续加大开放合作。与中广核、青岛安工院、广东工业大学签订3项战略合作协议,与中科院相关院所和清华大学、北京化工大学等20家科研院校组织技术交流,在羰基合成、PEEK、新型电解槽、绿色化工、节能降碳、CCUS等多个创新领域展开深度合作。与NEXANT、SABIC、ADNOC、SOCAR、TR等公司探索技术开发与合作,推动公司优势技术走向海外市场。成功承办第十二届世界化学工程大会暨第21届亚太化工联盟大会,第12分会场- 流程工业创新与过程系统工程再造分会,聚焦智能制造、数字化赋能、绿色低碳发展等主题,吸引全球化工领域近200名专家学者、企业代表和行业精英参会,共同探索行业科技创新与高质量发展的新路径。 本报告期内,本集团获省部级及以上各类科技进步类奖项共37项(次)。 本报告期内,本集团主要科技攻关成果:(1)茂名乙烯基弹性体关键技术开发及示范项目成功产出合格产品。该装置已完成满负荷标定,指标均优于设计指标。(2)镇海聚丙烯釜内合金成套技术开发一次投料试车成功。(3)脱油沥青气化成套技术开发和应用,全部技术指标达到设计目标。(4)海南炼化PBST可降解材料工业化成套技术开发与示范项目顺利打通全流程,产出合格产品。(5)青岛顺酐加氢法制丁二酸装置已产出合格丁二酸酐产品,装置运行稳定。 本报告期内,本集团新签各类技术开发合同309项,合同额合计达人民币5.32亿元;新签技术许可和技术转化类合同138项,合同额合计为人民币4.81亿元。 本报告期内,本集团新增专利申请762件,其中发明专利583件;新增授权专利307件,其中发明专利174件。截至本报告期末,本集团有效专利数为4,580件,其中发明专利2,440件。 引领工程建设行业新型工业化 本集团系统推动工程建设模式革新,积极推动先进技术装备应用,逐步改进传统工程建设方式,实现从传统模式到「标准精益设计+工厂化智造+装配化安装」的转变,走出一条具有工程建设行业特色的新型工业化道路。 强化全产业链一体化协同能力。深化一体化协同设计、一体化供应链管理、一体化设计可施工性研究、一体化项目界面管理。强化全域业务链流程标准化、数据链互联互通及工具链AI应用,优化工程建设一体化协同工作机制,为客户提供更好的全生命周期一体化协同增值服务。 (1)在设计端,构建知识图谱赋能效率提升,探索生成式设计转型,围绕乙烯装置、HAZOP安全等13项关键领域开展智能化专项研究,在智能审查、工艺安全分析、结构设计等场景形成专业模型,全厂流程优化、智能图纸与三维模型校审等取得实效。(2)在管理端,通过数字化技术赋能供应链协同,打造项目全生命周期供应链智能管理体系。统筹建设运营管理、项目管理、施工管理一体化平台,强化「数据+平台+应用」模式,推动标准化智慧工地建设。(3)在应用端,推进配管、物性库、流程模拟等国产工业软件攻关与土建、设备等三维设计软件深化应用。 进一步提升数智赋能能力。大力发展技术研发和智能化装配,重点在模块化智造、工厂化预制生产线、起重运输数字化模拟、智能装备等方面开展专项技术研发和推广应用。通过「机器代工」变革生产组织模式,加快推进智能装备研发和智能生产车间建设。 本报告期内,累计形成86项高效施工装备清单,发布覆盖焊接、调试、检测、供应链、绿色制造等多场景的《智能装备应用指南》。青岛智能化管道预制生产线完成组装测试;工艺管道自动焊接应用率提升至26%;无导轨爬行焊机、九轴╱ 六轴管道焊接机器人应用更加广泛,一次合格率达99.8%。试点推广罐内防腐全流程机器人作业、智能巡检机器狗与安全监控系统;推广电动叉车、高空作业平台等新能源工程机械。完成14,000吨环轨式起重机总体设计;深化AI在方案优化、施工调度中的应用,并启动「智慧起运」平台建设,强化起重运输数字化模拟能力。 推进装置智能化生产运维。拓展数字化工厂交付广度与深度,稳步推进全量、全要素高质量数字化交付。构建「系统代脑」数字孪生智能运维平台,融合动态运行数据与机理模型,实现远程诊断、预测性维护与工艺优化。加速「工艺远程技术支持中心」与「工艺远程智能支持服务平台」建设,形成可复制的典型应用。同步开展数字孪生、远程智能运维等专项课题研究,规划智能运维平台体系,持续提升装置全生命周期智能化运维服务水平,为客户创造高附加值运营保障。 业务展望 本集团2026年市场开发目标为:境内新签合同额人民币550亿元,境外新签合同额50亿美元。同时,重点将做好以下工作。 更大力度做好市场开发,筑牢发展根基。 本集团将坚定向工程服务价值链前端延伸,重点提升谘询、FEED、详细设计等高端服务能力。国内市场方面,持续稳固石油化工、煤化工、天然气及储运等传统基本盘,同时大力拓展绿氢、绿氨、绿醇及风光核电等新能源新领域;做强电子化学品、高性能工程塑料、碳纤维复合材料等高端新材料业务;推进生物航煤、生物基化学品及硫磷合成氨产业链开发;不断做大环境治理、节能降碳、循环经济的业务规模,打造新的业绩增长点。海外市场方面,深耕中东、中亚、北非等优势区域,持续开拓新的国别市场,构建多元均衡的全球市场布局;依托石油化工产业的传统优势,加快向新能源和低碳工程等新赛道延伸,推动国际业务持续升级。 更大力度加强项目管控。 项目是本集团经营的核心载体,本集团将从源头提升项目管理能力,加强项目源头策划,完善全生命周期经营风险动态监控机制,从前期就把好项目质量关、风险关。强化项目全过程管控,狠抓项目履约各环节,持续提升履约能力和盈利能力。始终坚守安全环保底线,持续提高QHSE绩效,筑牢公司安全、环保、绿色运营的根基。同时,深化数智化赋能,提升人工智能在项目管理中的应用水平,在设计优化和项目现场管理上加大投入,大力推广自动焊、焊接机器人等智能装备的应用,以数智化手段提升项目管理效能,降低运营成本。 更大力度推动协同创新。 本集团将整合内外部资源,深化与科研院所、高校及行业优质企业的合作,扩大优质技术源头供给,让创新成果更多、更快地转化为发展实效。强化研发、设计、制造、施工一体化的优势,将技术优势转化为盈利优势。抓好重大科技攻关项目的落地实施、投产示范与迭代提升,持续加强技术储备,为本集团业务发展提供持续的技术支撑。同时,加大本集团优势技术的推广应用与品牌推介,以技术引领市场、创造市场,不断提升公司在行业内的核心影响力和话语权。 全面提升风险防控能力。 本集团把风险防控放在更加重要的位置,强化全面风险管理,持续推动内控体系与合规、风险管理体系协同运作。加大项目风险防控力度,推进风险前置管理,严格把好项目立项关口,审慎推进项目决策,做实做细风险应对闭环管理。强化关键财务指标的边界管控与刚性约束,动态监控重点项目财务状况,精准识别、及时预警各类财务风险,确保公司资金、汇率、税务等各类风险总体平稳、安全可控,有效防范化解外部环境变化带来的各类风险,为本集团的稳健发展保驾护航。 按国际财务报告准则编制的财务数据和指标摘要 单位:人民币千元 项目 于2025年 12月31日 于2024年 12月31日 报告期末比 2024年度期末增减(%) 总资産 91,217,852 81,513,339 11.9 本公司权益持有人应占综合权益 31,741,999 31,512,063 0.7 本公司权益持有人的每股净资産 (人民币元) 7.22 7.17 0.7 单位:人民币千元 项目 截至12月31日止十二个月期间 报告期比 2024年同期增减(%) 2025年 2024年 收入 70,074,081 64,198,210 9.2 毛利 5,177,326 5,336,500 (3.0) 经营利润 1,279,115 1,715,213 (25.4) 税前利润 2,242,167 2,851,913 (21.4) 本公司权益持有人应占利润 1,797,681 2,465,727 (27.1) 基本每股盈利(人民币元) 0.41 0.56 (27.1) 经营活动所得╱(所用)的现金流量净额 8,186,346 (2,210,914) - 每股经营活动所得╱(所用)的现金流量净额(人民币元) 1.86 (0.50) - 项目 截至12月31日止十二个月期间 2025年 2024年 毛利率(%) 7.4 8.3 净利润率(%) 2.6 3.9 资産回报率(%) 2.1 3.0 权益回报率(%) 5.7 7.8 投入资本回报率(%) 5.8 7.9 项目 于2025年 12月31日 于2024年 12月31日 资産负债率(%) 65.1 61.3 ~ 完 ~ 本新闻稿由中国公关顾问有限公司代表中石化炼化工程(集团)股份有限公司发布。 有关中石化炼化工程(集团)股份有限公司 本集团是能源化工行业全产业链、全生命周期的综合服务商,拥有超70年的发展历史。业务覆盖石油炼制、石油化工、芳烃、新型煤化工、无机化工、医药化工、清洁能源、储运设施及环保节能等多个行业领域,为全球客户提供工程研发、技术谘询、技术许可、工程谘询、工程设计、项目管理、协助融资、EPC工程总承包以及物资采购、设备制造、施工安装、大型设备吊装和运输、预试车和开车、运营维护等全流程服务,在全球30多个国家和地区为客户成功交付了数百个投资庞大、工艺复杂、技术先进、质量优良的现代化工厂,积累了广泛且稳定的客户资源,享有卓越的行业影响力和社会声誉。 前瞻性陈述免责声明 本新闻稿包括「前瞻性陈述」。除历史事实陈述外,所有本公司预计或期待未来可能或即将发生的业务活动、事件或发展动态的陈述(包括但不限于预测、目标及其他预估及经营计划)都属前瞻性陈述。受诸多可变因素的影响,未来的实际结果或发展趋势可能会与这些前瞻性陈述出现重大差异。这些可变因素包括但不限于:价格波动、实际需求、汇率变动、市场份额、工业竞争、环境风险、法律、财政和监管变化、国际经济和金融市场条件、政治风险、项目延期、项目审批、成本估算及其它非本公司可控制的风险和因素。本公司幷声明,本公司今后没有义务或责任对今日做出的任何前瞻性陈述进行更新。 投资者及媒体查询 中石化炼化工程(集团)股份有限公司 董事会办公室 电话: (86) 10 5673 0525 电邮:seg.ir@sinopec.com 中国公关顾问有限公司 萧伟成 / 刘进 电话:(852) 2522 1838 / (852) 2522 1368 传真:(852) 2521 9955 电邮:seg@prchina.com.hk 2026-03-15 此财经新闻稿由EQS via SeaPRwire.com转载。本公告内容由发行人全权负责。原文链接: http://www.todayir.com/sc/index.php
More
HTVRONT凭借两款新型热压机扩大在沃尔玛的零售版图 Finance

HTVRONT凭借两款新型热压机扩大在沃尔玛的零售版图

(SeaPRwire) - 首先在Walmart推出的Mini Heat Press V2和10×10英寸Heat Press V2,以节省空间的设计和可靠性能为创作者及小规模销售者带来便利加利福尼亚州萨克拉门托,2026年3月15日——恰逢春季手工季,HTVRONT在Walmart推出两款升级款热转印机,专为日常制作者和小型企业创作者设计。 从3月14日起,新发布的HTVRONT Mini Heat Press V2和HTVRONT 10×10英寸Heat Press V2首先在全美Walmart门店亮相,通过当地Walmart门店让美国消费者更易获得专业品质的手工工具。 鉴于HTVRONT此前在Walmart推出的产品表现强劲且广受欢迎,两家公司通过推出这些新机器扩大合作。此次发布进一步巩固了HTVRONT在美国市场的地位,同时将其创新手工设备带入美国最具影响力的零售平台之一。 随着越来越多美国人将DIY手工转变为副业——从定制T恤、tote包到个性化礼品——创作者经济持续重塑人们在家工作和创作的方式。通过与Walmart合作,HTVRONT推出最新便携式热转印机,支持创作者打造小型企业。 HTVRONT Mini Heat Press V2:适合日常创作的紧凑型热转印机 这款迷你热转印机采用紧凑型设计,满足日常手工需求。尽管体积小,它能处理多种项目——从为学校用品制作姓名标签到装饰婴儿连体衣、定制tote包,再到与孩子一起做手工。它还可用于串珠图案设计等热门项目。 该机器专为家用设计,具备15分钟自动关机功能和绝缘安全底座,即使在餐桌上使用也很安全。其紧凑设计无需专用工作空间,甚至可兼作小型家用熨斗,用于快速创意任务。 HTVRONT 10×10英寸Heat Press V2:尺寸灵活,提升项目效率 这款热转印机配备灵活的10×10英寸加热板,平衡了生产效率与空间利用率。其紧凑尺寸可节省约20%的工作空间,非常适合小公寓、宿舍或拥挤的手工桌。 该尺寸仍足以应对大多数T恤热转印膜项目,同时足够精准,可处理袜子、眼罩和配饰等小物件。它还配备实时压力显示功能,让创作者更准确地监控施加的压力,在处理定制订单或经营小型企业时保持一致结果。 HTVRONT产品总监Tim表示:“我们发现许多手工爱好者希望获得专业工具,同时不牺牲宝贵的工作空间。通过Mini Heat Press V2和10×10英寸Heat Press V2,我们旨在提供强劲性能,同时保持设计紧凑和节省空间。” Walmart发言人回应道:“创作者经济往往从家庭开始,我们很高兴将HTVRONT纳入我们的Arts & Crafts品类。Mini Heat Press适合紧凑的日常手工,而10×10英寸Heat Press提供更大的压印区域,适用于更大的设计和更广泛的定制项目。” 此次发布标志着HTVRONT零售扩张的又一步,将其DIY手工工具从线上平台带入全美Walmart门店,让美国各地的创作者更易获得专业级设备。 如需了解HTVRONT的最新动态,请关注我们:Facebook: https://www.facebook.com/htvrontInstagram: https://www.instagram.com/htvrontTIKTOK: https://www.tiktok.com/@htvront 联系方式:品牌公关电子邮件:pr@htvront.com来源:HTVRONT https://www.htvront.com/ 本次公告的配图可通过以下链接获取:https://www.globenewswire.com/NewsRoom/AttachmentNg/8dc00e2f-bfaa-4d42-87ef-55ad11ceb928https://www.globenewswire.com/NewsRoom/AttachmentNg/883e6251-ea3f-4eed-8286-b554e4df4610https://www.globenewswire.com/NewsRoom/AttachmentNg/b82ff9f9-26c6-42da-8af7-58f48ee58e2c本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布,覆盖超过6,500个媒体库、86,000名编辑和记者,以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。
More
三亚崖州湾科技城(YZBSTC)闪耀亮相2026年国际海洋技术展览会 Finance

三亚崖州湾科技城(YZBSTC)闪耀亮相2026年国际海洋技术展览会

(SeaPRwire) - 30项深海“硬科技”创新成果亮相全球舞台伦敦,2026年3月14日——当地时间3月10日,全球顶级海洋技术展览会“2026年国际海洋技术展”(Oceanology International 2026,简称Oi2026)在英国伦敦正式开幕。三亚崖州湾科技城管理局联合China Merchants Sanya Deep-Sea Technology City Development Co., Ltd.,带领崖州湾科技城(YZBSTC)的海洋企业及机构代表团参与了这一海洋技术与海洋科学领域的重要全球交流平台。 在展会上,崖州湾科技城(YZBSTC)展台吸引了来自全球的专业观众。崖州湾科技城企业代表与国际海洋技术企业及科研机构的同行就产品特点、应用场景及潜在合作进行了交流,并就海洋装备研发、产品应用及国际市场拓展展开深入探讨。 此次展览中,崖州湾科技城管理局组织了园区内的一批海洋企业参展,包括Peneson Offshore Tech Sanya、Haidilong (Hainan) Intelligent Equipment、Hainan CathayBot Technology和Hainan Hengsheng Intelligent Technology。展会上展示了近30款先进海洋技术产品,涵盖深海装备、海洋观测、智能航海等技术领域,充分展现了崖州湾科技城企业在深海装备制造、水下探测技术及海洋智能装备领域的强大研发能力。 参与Oi2026是崖州湾科技城助力园区海洋科技企业“走出去”的重要举措。通过这一专业国际平台,崖州湾科技城企业不仅展示了技术成果,还对接了全球海洋产业链的上下游合作伙伴,进一步拓展了国际合作机遇。 未来,依托海南自由贸易港的开放优势,崖州湾科技城(YZBSTC)将继续搭建和升级国际交流合作平台,赋能更多海洋科技企业参与全球产业链,将更多“崖州湾科技城智造”推向全球舞台。 Company Name: Sanya Yazhou Bay Science and Technology City AdministrationContact: Toby ZhangEmail: tobyzhangworking@outlook.comState: 海南省三亚市Country: 中国Website: https://www.yazhou-bay.com本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布,覆盖超过6,500个媒体库、86,000名编辑和记者,以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。
More

InflaRx宣布收到纳斯达克关于最低股价要求的不合规通知

(SeaPRwire) - 德国耶拿,2026年3月13日——InflaRx N.V.(纳斯达克股票代码:IFRX)是一家通过靶向补体系统开发抗炎疗法的生物制药公司,该公司今日宣布已收到纳斯达克股票市场有限责任公司(“纳斯达克”)上市资格部门于2026年3月11日发出的书面通知(“通知”)。通知指出,在过去连续30个交易日中,该公司普通股的收盘价低于纳斯达克上市规则5450(a)(1)(“最低股价规则”)规定的每股1.00美元的持续上市最低要求。 根据纳斯达克上市规则5810(c)(3)(A),该公司获得了180个日历日的初始期限(即至2026年9月7日)以恢复合规。如果公司在此期间未能恢复对最低股价规则的合规,可考虑申请将其证券从纳斯达克全球精选市场转移至纳斯达克资本市场,前提是公司满足纳斯达克资本市场持续上市所需的公众持股适用市值以及除股价要求外的所有其他初始上市适用要求。此类转移将为公司提供额外180个日历日(即至2027年3月8日)以恢复合规。无法保证公司有资格获得额外的180天合规期(如适用),也无法保证纳斯达克工作人员会批准公司的持续上市请求。 该通知对公司普通股的上市或交易没有立即影响。公司拟监控其普通股的出价,并考虑可行选项以恢复对最低股价规则的合规。 关于InflaRx N.V.InflaRx(纳斯达克股票代码:IFRX)是一家生物制药公司,通过应用其专有的抗C5a和抗C5aR技术,发现、开发和商业化补体激活因子C5a及其受体C5aR的高效特异性抑制剂,从而开创抗炎疗法。C5a是一种强大的炎症介质,参与多种炎症疾病的进展。InflaRx的主要项目是izicopan(INF904),这是一种口服小分子抑制剂,通过C5a受体抑制C5a诱导的信号传导,在1期和2a期临床研究中显示出良好的药代动力学/药效学特征以及治疗潜力。该公司正在开发izicopan用于治疗多种炎症疾病,包括化脓性汗腺炎(HS)。公司还开发了vilobelimab,这是一种新型、静脉给药的首创抗C5a单克隆抗体,可选择性结合游离C5a,并在多项临床研究中显示出疾病修饰临床活性和耐受性。 InflaRx成立于2007年,集团在德国耶拿和慕尼黑以及美国密歇根州安阿伯设有办事处和子公司。如需更多信息,请访问www.inflarx.de。InflaRx GmbH(德国)和InflaRx Pharmaceuticals Inc.(美国)是InflaRx N.V.的全资子公司(合称InflaRx)。 联系方式: InflaRx N.V.MC Services AGJan Medina, CFA副总裁、投资者关系主管邮箱:IR@inflarx.deKatja Arnold, Laurie Doyle, Dr. Regina Lutz邮箱:inflarx@mc-services.eu欧洲:+49 89-210 2280美国:+1-339-832-0752 前瞻性陈述本新闻稿包含前瞻性陈述。除历史事实陈述外,所有陈述均为前瞻性陈述,通常由“可能”、“将”、“应该”、“预期”、“计划”、“预计”、“可能”、“打算”、“目标”、“项目”、“估计”、“相信”、“预测”、“潜在”或“继续”等术语表示,包括有关我们遵守最低股价规则以及普通股上市或交易的陈述。前瞻性陈述在本新闻稿中多处出现,可能包括有关我们的意图、信念、预测、展望、分析、当前预期以及我们向美国证券交易委员会(SEC)提交的定期报告中“风险因素”和“关于前瞻性陈述的警示声明”标题下描述的风险、不确定性和其他因素的陈述。这些陈述仅反映本新闻稿发布之日的情况,涉及已知和未知的风险、不确定性和其他重要因素,可能导致我们的实际结果、业绩或成就与前瞻性陈述中明示或暗示的任何未来结果、业绩或成就存在重大差异。鉴于这些风险、不确定性和其他因素,您不应过度依赖这些前瞻性陈述,除非法律要求,否则我们不承担更新这些前瞻性陈述的义务,即使未来有新信息可用。本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布,覆盖超过6,500个媒体库、86,000名编辑和记者,以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。
More

Jayud Global Logistics 宣布 670 万美元注册直接发行定价

(SeaPRwire) - 中国深圳,2026年3月13日 -- Jayud Global Logistics Limited(纳斯达克股票代码:JYD)(简称“Jayud”或“公司”)是一家总部位于深圳、专注于跨境物流的领先端到端供应链解决方案提供商。公司今日宣布,已与数名投资者签署证券购买协议,以每股1.34美元的价格通过注册直接发行(简称“本次发行”)购买和出售5,025,000股A类普通股。公司预计本次发行的募集资金总额约为673万美元。 在满足惯例结案条件的情况下,本次发行预计将于2026年3月17日或前后完成。 FT Global Capital, Inc. 担任本次发行的独家配售代理。 公司拟将本次发行的募集资金净额用于一般企业用途,包括营运资金和海外业务运营的扩张。 本次发行中的证券是根据之前向美国证券交易委员会(简称“SEC”)提交并于2024年7月3日根据经修订的《1933年证券法》(简称“《证券法》”)宣布生效的F-3表格(文件号:333-280010)上的有效“搁置”注册声明进行的。与本次发行相关的招股说明书补充文件及随附的招股说明书将提交至SEC,并可在SEC网站www.sec.gov上查阅。 本新闻稿不构成出售这些证券的要约或购买这些证券的要约邀请,在根据任何此类州或司法管辖区的证券法进行注册或取得资格之前,如果在该州或司法管辖区此类要约、邀请或出售属于违法行为,则不得在该州或司法管辖区出售这些证券。 关于 Jayud Global Logistics Limited Jayud Global Logistics Limited 是中国领先的总部位于深圳的端到端供应链解决方案提供商之一,专注于跨境物流服务。公司受益于独特的地理优势,为海运、空运和陆运物流提供高度支持。作为 Alibaba.com 的核验供应商,Jayud 已建立了一个全球运营网络,在中国及世界各地的主要交通枢纽设有物流设施,足迹遍布中国大陆12个省份和六大洲的16个国家。Jayud 提供全面的跨境供应链解决方案,包括货运代理、供应链管理和其他增值服务。凭借其在专有IT系统方面强大的服务和研发能力,公司提供定制化、高效的物流解决方案,并建立了长期的客户关系。欲了解更多信息,请访问公司网站:https://ir.jayud.com。 前瞻性声明 本公告中的某些陈述属于前瞻性陈述。这些前瞻性陈述涉及已知和未知的风险和不确定性,并基于公司目前对公司认为可能影响其财务状况、经营业绩、业务战略和财务需求的未来事件的预期和预测。投资者可以通过“可能”、“将”、“预期”、“预料”、“目标”、“估计”、“意图”、“计划”、“相信”、“很可能”、“潜力”、“继续”或其他类似表达来识别这些前瞻性陈述。除法律要求外,公司不承担公开更新或修订任何前瞻性陈述以反映随后发生的事件或情况,或其预期变化的义务。虽然公司认为这些前瞻性陈述中表达的预期是合理的,但不能向您保证此类预期将被证明是正确的,公司提醒投资者,实际结果可能与预期结果存在重大差异,并鼓励投资者在公司的注册声明和提交给SEC的其他文件中查看可能影响其未来业绩的其他因素。 欲了解更多信息,请联系: Jayud Global Logistics Limited投资者关系部电子邮箱:ir@jayud.com 投资者关系联系人:Matthew Abenante, IRC总裁Strategic Investor Relations, LLC 电话:347-947-2093电子邮箱:matthew@strategic-ir.com本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布,覆盖超过6,500个媒体库、86,000名编辑和记者,以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。
More
AdsDrama Launches Short-Drama Marketing Ecosystem Launch in the Dominican Republic, Paving the Way for Digital Content Innovation ACN Newswire

AdsDrama Launches Short-Drama Marketing Ecosystem Launch in the Dominican Republic, Paving the Way for Digital Content Innovation

Santo Domingo, Dominican Republic, Mar 14, 2026 - (ACN Newswire via SeaPRwire.com) - In a strategic move to tap into the booming global short-drama market, AdsDrama LTD, an international digital content marketing company registered in Denver with $50 million in capital, has officially launched its tailored short-drama marketing ecosystem in the Dominican Republic. This event marks the company’s key step in expanding its global footprint, aiming to bridge the local content supply gap and build a sustainable digital entertainment model that combines its core strengths in advertising technology and community-driven growth.Short dramas — dozens of 1–3 minute episodes with fast-paced, emotional storytelling—are booming globally, fitting today's fragmented viewing habits. AdsDrama LTD, an international digital content marketing firm, is building a short-drama marketing ecosystem in the Dominican Republic, combining ad technology and community-driven strategies for sustainability.Short Dramas: The Next Digital Entertainment Growth EngineGlobal entertainment has shifted from long-form to short-form content, with short dramas offering advantages: 1–3 minute episodes, engaging storylines, mobile optimization, and higher monetization. The "free viewing + paid unlocking" model effectively retains audiences and generates revenue, fostering a full ecosystem of production, marketing, and commercialization.AdsDrama: Focused on Short-Drama MarketingRegistered in Denver with $50 million capital, AdsDrama's mission is a global short-drama marketing ecosystem integrating ad technology, distribution, data-driven strategies, and community promotion. Its core businesses include short-drama marketing, ad services, commercial operations, custom production, and IP incubation. Operating via "global technology + local operations," it adapts global expertise to local markets.Digital Advertising: The Growth EngineEffective distribution is key for short dramas. AdsDrama promotes content across social media, short-video platforms, portals, and search channels, optimizing campaigns via data analytics. Revenue streams include advertising, paid content, brand partnerships, and IP commercialization—forming the industry's financial foundation.Community-Driven "Co-Builder" ModelAdsDrama's "co-builder ecosystem" invites local participants to share content, provide market feedback, and expand reach. In return, co-builders get marketing materials, data access, and training—leveraging community trust, which outweighs algorithmic traffic in Latin America.User Experience & VIP StructureNew users get a free trial (RD$25–RD$60) to learn the platform's workflow and revenue model. For deep engagement, VIP levels (e.g., VIP3: RD$16,200 participation, daily returns of RD$270–RD$648 for 730 days) offer tiered benefits, with automatic revenue calculation and principal return options post-cooperation.Why the Dominican Republic?The country is a key market due to its young population (high digital entertainment demand), widespread mobile internet usage, and a gap in professionally produced short dramas—creating ideal conditions for ecosystem development.Three-Phase Development StrategyAdsDrama's 3-year plan: Phase 1 (1–6 months): Launch flagship dramas, build user communities, optimize marketing; Phase 2 (7–18 months): Expand promotion, improve operations, diversify revenue; Phase 3 (19–36 months): Open to independent creators, build a comprehensive ecosystem, and expand to the Caribbean and Latin America.The Future of the Digital Content EcosystemAs mobile internet continues to evolve, the digital entertainment industry is undergoing constant transformation.Short videos changed how audiences consume media. Short dramas may represent the next stage of this evolution - combining storytelling, advertising, and digital commerce in a single content format.Companies like AdsDrama LTD believe that the future of digital content will rely on the integration of multiple elements:creative storytellingtechnology infrastructuredata-driven marketingcommunity-based promotionIn this ecosystem:creators focus on producing contentplatforms provide technology and marketing toolscommunities help amplify distributionTogether, these elements form a sustainable and scalable digital content economy.Short dramas represent the next evolution of digital entertainment, integrating storytelling, advertising, and commerce. AdsDrama's focus on infrastructure, community, and data will drive the industry's growth, with the Dominican Republic and Latin America at the forefront of this transformation.Media contactBrand: AdsDrama LTDContact: Media teamWebsite: https://www.adsdrama.com Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More

蓝帽互动娱乐科技宣布公司收到纳斯达克退市通知且有待听证会裁决

(SeaPRwire) - 中国厦门,2026年3月13日——开曼群岛豁免公司蓝帽互动娱乐科技有限公司(“蓝帽”或“公司”)(纳斯达克股票代码:BHAT)今日宣布,公司于2026年3月9日收到纳斯达克股票市场有限责任公司(“纳斯达克”)发出的一份决定函(“函件”),通知公司不符合纳斯达克上市规则5810(c)(3)(A)(iii)(“低价股票规则”),因为公司证券在2026年2月23日至2026年3月6日期间连续十个交易日的收盘价为0.10美元或更低。该函件表明,因此,纳斯达克工作人员已决定将公司的普通股从纳斯达克资本市场退市(“退市决定”)。 此前,在2025年4月2日,蓝帽重新符合了纳斯达克的最低出价价格要求。同时,根据纳斯达克上市规则5815(d)(4)(B),公司自此需接受为期一年的强制小组监管,直至2026年4月2日,以监督公司持续符合最低出价价格要求。函件通知称,自2026年2月23日以来,公司证券的收盘价连续十个交易日为0.10美元或更低。因此,公司需遵守纳斯达克上市规则5810(c)(3)(A)(iii)(“低价股票规则”)的相关规定。由于此情况以及小组监管,函件称纳斯达克已决定将公司证券从纳斯达克资本市场退市。公司被给予至2026年3月16日的时间,以请求对退市决定向听证小组提出上诉(“上诉”)。 公司普通股的交易将于2026年3月16日开市时暂停(“暂停”),并将向美国证券交易委员会(“SEC”)提交25-NSE表格,这将使公司证券从纳斯达克股票市场退市并取消注册。及时上诉不会暂停交易。 公司已向纳斯达克听证小组提交听证请求,作为寻求继续在纳斯达克资本市场上市的下一步流程。然而,无法保证公司的上诉能够成功,也无法保证公司最终能够继续在纳斯达克资本市场上市。 关于蓝帽互动娱乐科技有限公司 蓝帽曾是一家通信服务提供商,也是中国AR互动娱乐游戏、玩具及教育材料的生产商、开发商和运营商。凭借多年的技术积累和独特的专利技术,蓝帽正在将其业务扩展至商品交易领域,旨在成为全球领先的智能商品交易商。如需更多信息,请访问公司投资者关系网站http://ir.bluehatgroup.com。公司会定期在其网站上提供重要信息。 前瞻性声明 本新闻稿包含经修订的1933年《证券法》第27A条和经修订的1934年《证券交易法》第21E条所定义的前瞻性声明。所有前瞻性声明本质上都是不确定的,因为它们基于公司对未来事件或未来业绩的当前预期和假设。提醒读者不要过度依赖这些前瞻性声明,这些声明只是预测,仅在本新闻稿发布之日有效。在评估此类声明时,潜在投资者应仔细审查本新闻稿中识别出的各种风险和不确定性以及公司向美国证券交易委员会提交的文件中所述事项。这些风险和不确定性可能导致公司的实际结果与前瞻性声明中所表明的结果存在重大差异。 联系信息: 蓝帽互动娱乐科技有限公司电话:+86 (592) 228-0010电子邮件:ir@bluehatgroup.net本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布,覆盖超过6,500个媒体库、86,000名编辑和记者,以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。
More
SuisseGold.com 推出 Tether 支付服务,支持购买实物黄金与白银,进一步拓宽加密货币兑换贵金属渠道 Finance

SuisseGold.com 推出 Tether 支付服务,支持购买实物黄金与白银,进一步拓宽加密货币兑换贵金属渠道

(SeaPRwire) - 香港,2026年3月13日 -- SuisseGold 宣布在其全线实物贵金属产品中推出 Tether (USDT) 支付功能,使客户能够使用全球最广泛使用的稳定币之一购买金、银、铂、钯和铑条及硬币。 此举使这家金银交易商跻身于越来越多将稳定币基础设施整合到传统资产市场的金融服务提供商之列。SuisseGold 上的所有产品现均以 USDT 实时定价,允许数字资产持有者直接将稳定币转换为实物金银,而无需依赖传统的银行渠道。 该公司表示,此次整合反映了投资者寻求将数字资产多元化配置为有形硬资产的需求日益增长。 “稳定币已成为全球金融中的主要结算层,”公司发言人表示。“通过接受 USDT,我们正在为全球客户搭建一座连接区块链资本与实物贵金属的直接桥梁。” 实时定价与区块链结算 在新系统中,客户可以在线选择金银产品并在结账时选择 Tether (USDT)。定价基于当前的金属现货价格,以 USDT 实时显示。一旦区块链交易得到确认和验证,订单即会进行处理。 SuisseGold 指出,加密货币交易是不可逆的,客户在转账前必须核实钱包详细信息。 此举正值稳定币在跨境商业中的应用日益广泛之际。由于 USDT 与美元挂钩,与波动较大的加密货币相比,它提供了价格稳定性,降低了购买时的交易不确定性。 对贵金属市场的战略意义 行业分析师指出,数字资产与传统避险投资的融合是一个日益增长的趋势。稳定币被广泛用于加密货币交易和国际结算,正越来越多地被应用于现实世界的交易中。 通过整合 USDT 支付,SuisseGold 提供了: 与美元挂钩的交易稳定性相比银行电汇更快的跨境结算速度潜在更低的国际转账成本全球 24/7 全天候购买渠道 数字资产与硬资产的结合 此次发布凸显了投资者管理流动性和投资组合多元化方式的更广泛转变。随着稳定币在全球范围内的流通持续扩大,能够实现向实物资产转换的平台正变得越来越重要。 SuisseGold 表示,所有金银产品——包括低溢价的金银条和投资级硬币——现在均可使用 USDT 购买。 该公司向稳定币支付的扩展突显了连接区块链金融与传统财富保值资产的基础设施正在不断演进,标志着数字市场与实体市场交叉领域的持续创新。 如需更多信息,请访问 SuisseGold.com。 媒体联系人: 新闻联系人姓名:Elena Moretti公司名称:Suisse Gold网站:https://suissegold.com电子邮件:pr@suissegold.com 免责声明:本内容由 Suisse Gold 提供。本内容中表达的陈述、观点和意见仅代表内容提供者,并不一定反映本媒体平台或其出版商的观点。我们不对所提供信息的准确性、完整性或可靠性进行背书、核实或保证。我们不对本文中做出的任何声明、陈述或承诺提供保证。本内容仅供参考,不应被视为财务、投资或交易建议。投资加密货币和与挖矿相关的机会涉及重大风险,包括资本损失的可能性。您有可能损失全部资本。这些产品可能并不适合所有人,您应确保了解所涉及的风险。如有必要,请寻求独立建议。仅使用您能承受损失的资金进行投机。强烈建议读者在做出任何投资决定之前进行自己的研究并咨询合格的财务顾问。然而,由于区块链行业(包括加密货币、NFT 和挖矿)固有的投机性质,无法保证完全的准确性。对于因本新闻稿内容而引起的任何欺诈活动、虚假陈述或财务损失,媒体平台和出版商均不承担任何责任或义务。如果针对本文提出任何法律索赔或指控,我们不承担任何责任或义务。Globenewswire 不对本页面上的任何内容进行背书。法律免责声明:本媒体平台以“现状”为基础提供本文内容,不提供任何明示或暗示的保证或陈述。我们对任何不准确、错误或遗漏不承担任何责任。我们不对本文所提供信息的准确性、内容、图像、视频、许可、完整性、合法性或可靠性承担任何责任或义务。与本文相关的任何疑虑、投诉或版权问题应直接向上述内容提供者提出。本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布,覆盖超过6,500个媒体库、86,000名编辑和记者,以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。
More
General MRO Aerospace Achieves CAAC Certification, Expanding Global Maintenance Capabilities ACN Newswire

General MRO Aerospace Achieves CAAC Certification, Expanding Global Maintenance Capabilities

MIAMI, FL, Mar 13, 2026 - (ACN Newswire via SeaPRwire.com) - General MRO Aerospace (GMA) today announced that it has officially received certification from the Civil Aviation Administration of China (CAAC), authorizing the company to perform maintenance, repair, and overhaul (MRO) services for components on Chinese-registered aircraft.The certification marks a significant milestone in General MRO Aerospace's international growth strategy and further validates the company's commitment to the highest standards of safety, quality, and regulatory compliance."Achieving CAAC certification is an important step forward for General MRO Aerospace as we continue to expand our global footprint," said Jonathan Cornell, President of General MRO Aerospace. "This approval demonstrates the strength of our quality systems, our technical expertise, and our commitment to supporting Airline and MRO partners worldwide."The CAAC approval allows GMA to provide repair and overhaul services for a range of aircraft components in accordance with Chinese aviation regulatory requirements. The certification process included a comprehensive audit of the company's facilities, quality management system, technical procedures, and regulatory compliance programs.General MRO Aerospace already operates under FAA Part 145, EASA, CAA, and CAAT quality standards, and the addition of CAAC certification enables the company to better serve operators, lessors, and maintenance providers across the Asia-Pacific aviation market."With increasing global demand for high-quality component repair services, this certification strengthens our ability to support customers operating in China and throughout the region," Cornell added. "We look forward to building strong partnerships with Chinese airlines and aviation organizations."General MRO Aerospace specializes in the repair and overhaul of complex aircraft components, supporting commercial and cargo operators worldwide with reliable turnaround times, technical excellence, and customer-focused service.About General MRO AerospaceGeneral MRO Aerospace is an AS9110 and ISO 9001 accredited U.S.-based aviation maintenance, repair, and overhaul provider specializing in component repair and support services for commercial aircraft operators worldwide. Operating under FAA Part 145, EASA, CAA, CAAT, and CAAC certification, the company delivers high-quality technical solutions, responsive customer service, and dependable turnaround times to airlines, leasing companies, and MRO partners around the globe.Media ContactMichelle TorresMarketing SpecialistGeneral MRO AerospaceMtorres@GeneralMROAerospace.comwww.GeneralMROAerospace.comSOURCE: General MRO Aerospace Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More